ARCHIVES

Cancer Groups Endorse Pazdur For FDA Commissioner.

This article is from The Cancer Letter archive.

Vol. 27 No. 03 | January 19, 2001

Download PDF Visit The Full Archive

Related Articles

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004

ACS names new officers.

December 5, 2003

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006

New Biomedical Research Panel Accepts Broad Mandate. May Suggest Separate Health Dept.

February 28, 1975